Choksi Laboratories
- Market cap
- ₹ 146 Cr.
- P/E
- 76.2x
- P/B
- 5.7x
- 52-week range
- 81.85 – 226.65
- ROE
- 6%
- ROCE
- 9.6%
- Dividend yield
- 0%
- Debt / equity
- 1.34
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- BSE
About
Choksi Laboratories Limited is an India-based provider of contract testing and analytical services. The Company analyzes, for its clients, or as a regulatory requirement, pharmaceuticals, food and agricultural products, construction materials, chemicals, calibration and environmental monitoring services. It operates through a single segment, which is analysis and testing. The Company's services include contract laboratory services, instrument calibration and validation services, environmental management services, clinical research, consultancy, and assaying and hallmarking (gold and silver). The Company's contract laboratory services include pharmaceutical analysis, food and beverages analysis, water analysis and construction material analysis. Its calibration services include laboratory and on-site calibration for test equipment, process equipment and, in many cases, end-user equipment; plant shutdown calibration, and consultancy for setting up an in-house calibration laboratory.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Choksi Laboratories against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)76.2 against a typical 20.5: pricier than most peers (1st = cheapest).29th of 34
- Sales growth+7.3% against a typical +19.1% from a year earlier.24th of 31
- Profit growth+48.7% against a typical +25.2% from a year earlier.4th of 24
- Share price, 3 months+93.7% against a typical −7.5%.2nd of 33
- Size₹ 146.3 Cr. market value against a typical ₹ 83 Cr. (1st = largest).14th of 34
Research by Minerva Capital Research Solutions
Our research team's work on Choksi LaboratoriesAlso covered in
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8 | 9 | 11 | 11 | 9 | 10 | 11 | 11 | 11 | 11 | 13 | 12 |
| Expenses | 6 | 7 | 8 | 8 | 7 | 8 | 8 | 8 | 8 | 8 | 9 | 9 |
| Operating Profit | 2 | 2 | 3 | 3 | 2 | 3 | 4 | 3 | 3 | 3 | 4 | 3 |
| OPM % | 26.5% | 25.5% | 31.4% | 26.4% | 25.5% | 24.5% | 30.7% | 25.8% | 26.4% | 24.6% | 28.4% | 27.2% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax % | 0% | 57.1% | 46.5% | 30.7% | 20% | 44.4% | 27% | 38.7% | 57.1% | 64.8% | 6.4% | 3.3% |
| Net Profit | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| EPS in Rs | 0.01 | 0.09 | 0.98 | 0.6 | 0.11 | 0.16 | 1.32 | 0.56 | 0.34 | 0.45 | 1.48 | 0.83 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 6%
- 5 Years
- 12%
- 3 Years
- 10%
- TTM
- 11%
- 10 Years
- 7%
- 5 Years
- 21%
- 3 Years
- −3%
- TTM
- 27%
- 10 Years
- 26%
- 5 Years
- 52%
- 3 Years
- 35%
- TTM
- —
- 10 Years
- 3%
- 5 Years
- 6%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Choksi Laboratories | ₹ 213.95 | ₹ 146 Cr. | 76.2x | 5.7x | 6% | — |
| Swiggy | ₹ 176.70 | ₹ 48,775 Cr. | — | 3.3x | — | −15.1% |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 206.6x | 3.2x | — | 0.8% |
| Urban Company | ₹ 132.65 | ₹ 20,457 Cr. | — | 10.5x | — | −19.5% |
| Sagility | ₹ 44.10 | ₹ 20,645 Cr. | 22.4x | 2.2x | — | 13% |
| Indegene | ₹ 570.00 | ₹ 13,763 Cr. | 34.1x | 4.5x | — | 10.5% |
Management
- Sunil Kumar Choksi
- Executive Chairman of the Board, Managing Director
- Stela Choksi
- Chief Financial Officer, Whole Time Director
- Prakhar Dubey
- Compliance Officer, Company Secretary
- Himika Choksi
- Whole Time Director
- Vyangesh Choksi
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.